Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aceragen, Inc. | CHIEF EXECUTIVE OFFICER, Director | Stock Options (Right to Buy) | 74.5K | Jan 20, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACGN | Aceragen, Inc. | Jan 20, 2023 | 1 | $0 | 4 | Feb 2, 2023 | CHIEF EXECUTIVE OFFICER, Director |
ACGN | Aceragen, Inc. | Jan 17, 2023 | 2 | $0 | 4 | Jan 19, 2023 | Chief Executive Officer, Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Sep 28, 2022 | 2 | $0 | 4 | Sep 30, 2022 | Chief Executive Officer, Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Sep 28, 2022 | 0 | $0 | 3 | Sep 30, 2022 | Chief Executive Officer, Director |